The gastric cancer diagnostic procedure market is expected to grow from US$ 1307.96 million in 2022 to US$ 1912.03 million by 2028; it is estimated to register a CAGR of 6.5% from 2022 to 2028.
The gastric cancer diagnostic procedure market is segmented on the basis of healthcare provider, symptom type, body fluid, procedure, offering, disease indication, and geography. The report offers insights and in-depth analysis of the market, emphasizing parameters such as dynamics, trends, and opportunities in the gastric cancer diagnostic procedure market and competitive landscape analysis of leading market players across various regions. It also includes the impact analysis of COVID–19 pandemic on the market across these regions.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Gastric Cancer Diagnostic Procedure Market: Strategic Insights
Market Size Value in US$ 1307.96 million in 2022 Market Size Value by US$ 1912.03 million by 2028 Growth rate CAGR of 6.5% from 2022 to 2028 Forecast Period 2022-2028 Base Year 2022
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Gastric Cancer Diagnostic Procedure Market: Strategic Insights
Market Size Value in | US$ 1307.96 million in 2022 |
Market Size Value by | US$ 1912.03 million by 2028 |
Growth rate | CAGR of 6.5% from 2022 to 2028 |
Forecast Period | 2022-2028 |
Base Year | 2022 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to AnalystLucrative Regions in Gastric Cancer Diagnostic Procedure Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Market Insights
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Rise in Prevalence of Gastrointestinal Diseases
Despite declining incidence and mortality during the last decades, stomach cancer is perceived as one of the main health challenges worldwide. According to the GLOBOCAN, stomach cancer caused ~800,000 deaths (accounting for 7.7% of all cancer-related deaths) in 2020. The disease ranks as the fourth leading cause of cancer deaths in both genders combined. ~1.1 million new cases of stomach cancer were diagnosed in 2020, accounting for 5.6% of all cancer cases. Asia accounts for ~75% of the new stomach cancer cases and deaths reported globally. Western countries, such as the US and Canada, report high GI disease incidence rates, which can be attributed to increasing obesity in the adult population and less consumption of dietary fibers. According to data released by the Centers for Disease Control and Prevention in December 2022, physicians’ offices in the US record ~37.2 million cases of digestive system diseases.
The prevalence of irritable bowel syndrome (IBS) has increased across the world in the last few decades. According to the International Foundation for Gastrointestinal Disorders, Inc., IBS is the most common functional GI disorder, with a global prevalence rate of 10–15%. Also, physicians in the US record ~2.4–3.5 million visits of IBS patients annually. Although the overall incidence rate of gastric cancer has been declining over the years, it has surged among young adults during the past several decades. Thus, the increasing prevalence of gastrointestinal (GI) disease results in a high risk of developing gastric cancer, which drives the growth of the gastric cancer diagnostic procedure market.
Healthcare Provider-Based Insights
The global gastric cancer diagnostic procedure market, based on healthcare provider, is segmented into diagnostic laboratories, hospitals, cancer research institutes, oncology specialty clinics, and others. In 2022, the hospitals segment held the largest share of the market. The market for the cancer research institutes segment is expected to grow at the highest CAGR during the forecast period.
Gastric Cancer Diagnostic Procedure Market, by Healthcare Provider – 2022–2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Symptom Type-Based Insights
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
The gastric cancer diagnostic procedure market, by symptom type, is bifurcated into symptomatic and asymptomatic. In 2022, the asymptomatic segment held a larger market share. However, the symptomatic segment is estimated to register a higher CAGR during the forecast period.
Body Fluid-Based Insights
Based on body fluid, the gastric cancer diagnostic procedure market is segmented into blood, urine, saliva, stomach wash/gastric juice, tissue, and others. In 2022, the blood segment held the largest market share. However, the market for the tissue segment is expected to grow at the fastest CAGR during the forecast period.
Procedure-Based Insights
Based on procedure, the gastric cancer diagnostic procedure market is segmented into endoscopic procedures, biopsy and tissue tests, lab tests, in-vitro diagnostic tests, imaging tests, molecular diagnostics, multiplexing molecular diagnostics and immunoassays, and others. In 2022, the imaging tests segment held the largest market share. The market for the biopsy and tissue tests segment is estimated to register a higher CAGR during the forecast period.
Offering-Based Insights
The gastric cancer diagnostic procedure market, based on offerings, is segmented into instruments, reagents and consumables, and services. In 2022, the reagents and consumables segment held the largest share of the market. The market for the services segment is estimated to register a higher CAGR during the forecast period.
Disease Indication-Based Insights
Based on disease indication, the gastric cancer diagnostic procedure market is segmented into early gastric cancer and advanced gastric cancer. In 2022, the advanced gastric cancer segment held a larger share of the market. The market for the same segment is expected to grow at a higher CAGR during the forecast period.
COVID-19 Insights
Preventive measures such as deliberately expanding the physical space to avoid close contacts and spread of illness, and mandating the use of masks in workplaces were implemented in several countries for reducing the spread of SARS-CoV-2. However, various restrictions resulted in the cancellation or rescheduling of appointments for gastric cancer diagnosis and treatments. According to a study published in 2021 in PubMed, significantly fewer patients were diagnosed with stage-I gastric and colorectal cancers during the COVID-19 phase. After the first quarter of 2020, the demand for gastric cancer diagnostics increased in the government and private institutions for testing COVID-19 patients for H. pylori infection. Furthermore, patients with advanced stages of gastric cancer were prioritized for diagnosis and treatment, which led to the gastric cancer diagnostic procedure market growth amid the COVID-19 crisis.
The gastric cancer diagnostic procedure market players adopt organic strategies such as product launch and expansion to expand their footprint and product portfolio worldwide and meet the growing demand. Partnerships and collaborations are among the inorganic growth strategies witnessed in the market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence. Additionally, acquisitions, partnerships, and other growth strategies help companies to strengthen customer base and increase their product portfolios.
- In February 2023, CARsgen Therapeutics announced a collaboration agreement with F. Hoffmann-La Roche (Roche) to assess AB011 and atezolizumab to treat gastric cancer. The collaboration will evaluate CARsgen’s investigational drug AB011, Roche’s PD-L1 checkpoint inhibitor atezolizumab, and the standard-of-care chemotherapy combination in gastric or gastroesophageal junction carcinoma patients.
- In January 2023, Agilent Technologies announced a partnership with Akoya Biosciences to develop chromogenic and immunofluorescent multiplex assays that include spatial analysis for biopharma companies engaged in developing precision cancer therapeutics. This partnership enables an ecosystem that assists the development of novel precision cancer therapeutics and offers a streamlined workflow to the customers of both these companies in the clinical research market.
- In August 2022, MiRXES launched a series of new capabilities—including an Industry 4.0 manufacturing facility, two new laboratories, and a collaborative multi-cancer screening research project. The new developments are aligned with MiRXES’ goal of advancing its research and production capabilities to develop miRNA-based disease detection tests.
- In July 2022, MiRXES Pte Ltd launched the world’s first large-scale clinical research project—CADENCE (CAncer Detected Early caN be CurEd). The Project CADENCE aims to develop a multi-cancer early detection test for up to nine high-incidence and high-mortality cancers: lung, breast, colorectal, liver, stomach (gastric), esophageal, ovarian, pancreatic, and prostate cancers.
Gastric Cancer Diagnostic Procedure Market - Company Profiles
- Atlas-Link Biotech Co Ltd
- Bio-Rad Laboratories Inc
- MiRXES Pte Ltd
- Agilent Technologies Inc
- F. Hoffmann-La Roche Ltd
- bioMerieux SA
- Thermo Fisher Scientific Inc
- Illumina Inc
- Vela Diagnostics Holding Pte Ltd
- Myraid Genetics Inc
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Healthcare Provider, Symptom Type, Body Fluid, Procedure, Offering, and Disease Indication
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Asia Pacific is expected to be the fastest-growing region in the gastric cancer diagnostic procedure market over the forecast period due to the increasing surging cases of helicobacter pylori infection and the rise in the prevalence of gastrointestinal diseases.
The gastric cancer diagnostic procedure market is expected to be valued at US$ 1912.03 million by 2028.
The hospitals segment held the largest share of the market in 2022. Also, the cancer research institutes segment is estimated to register the highest CAGR in the market during the forecast period.
The gastric cancer diagnostic procedure market is estimated to be valued at US$ 1307.96 million in 2022.
The CAGR value of the gastric cancer diagnostic procedure market during the forecasted period is 6.5%%.
The gastric cancer diagnostic procedure market majorly consists of the players, such as Atlas-Link Biotech Co Ltd, Bio-Rad Laboratories Inc, MiRXES Pte Ltd, Agilent Technologies Inc, F. Hoffmann-La Roche Ltd, bioMerieux SA, Thermo Fisher Scientific Inc, Illumina Inc, Vela Diagnostics Holding Pte Ltd, and Myraid Genetics Inc.
Gastric cancer is a type of malignant cancer that forms the stomach's inner lining. Risk factors such as age, diet, and stomach diseases can lead to the development of gastric cancer. Symptoms of gastric cancer include indigestion, heartburn, bloating, and stomach discomfort or pain.
The factors that are driving the growth of the gastric cancer diagnostic procedure market are the rise in alcohol consumption, smoking, surging cases of Helicobacter pylori infection, and the rise in the prevalence of gastrointestinal diseases. These are some of the major factors contributing to the growth of the gastric cancer diagnostic procedure industry.
The List of Companies - Gastric Cancer Diagnostic Procedure Market
- Atlas-Link Biotech Co Ltd
- Bio-Rad Laboratories Inc
- MiRXES Pte Ltd
- Agilent Technologies Inc
- F. Hoffmann-La Roche Ltd
- bioMerieux SA
- Thermo Fisher Scientific Inc
- Illumina Inc
- Vela Diagnostics Holding Pte Ltd
- Myraid Genetics Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Gastric Cancer Diagnostic Procedure Market
Feb 2023
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Feb 2023
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2023
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2023
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2023
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2023
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2023
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Feb 2023
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)